Found: 16
Select item for more details and to access through your institution.
Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children's Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 7, p. 1416, doi. 10.3390/jcm10071416
- By:
- Publication type:
- Article
Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort.
- Published in:
- Rare Tumors, 2024, p. 1, doi. 10.1177/20363613241271669
- By:
- Publication type:
- Article
Metabolic response as assessed by <sup>18</sup>F‐fluorodeoxyglucose positron emission tomography‐computed tomography does not predict outcome in patients with intermediate‐ or high‐risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee
- Published in:
- Cancer Medicine, 2021, v. 10, n. 3, p. 857, doi. 10.1002/cam4.3667
- By:
- Publication type:
- Article
Osteogenic Sarcoma: Systemic Chemotherapy Options for Localized Disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pain and Analgesia in Children with Cancer after Hemipelvectomy: A Retrospective Analysis.
- Published in:
- Children, 2022, v. 9, n. 2, p. 237, doi. 10.3390/children9020237
- By:
- Publication type:
- Article
Identification of clinically achievable combination therapies in childhood rhabdomyosarcoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Event‐free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 7, p. 1, doi. 10.1002/pbc.31009
- By:
- Publication type:
- Article
Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 4, p. 1, doi. 10.1002/pbc.30847
- By:
- Publication type:
- Article
Feasibility of combining temsirolimus to vincristine, dactinomycin, cyclophosphamide, and vincristine and irinotecan chemotherapy for children with intermediate‐risk rhabdomyosarcoma: A report from Children's Oncology Group.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 9, p. 1, doi. 10.1002/pbc.30436
- By:
- Publication type:
- Article
Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Dose-response effect of eribulin in preclinical models of osteosarcoma by the pediatric preclinical testing consortium.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Initial in vivo testing of a multitarget kinase inhibitor, regorafenib, by the Pediatric Preclinical Testing Consortium.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Alveolar soft part sarcoma in children and young adults: A report of 69 cases.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Two cases of humoral hypercalcemia of malignancy complicating infantile fibrosarcoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Survivorship.
- Published in:
- Journal of Surgical Oncology, 2015, v. 111, n. 5, p. 648, doi. 10.1002/jso.23844
- By:
- Publication type:
- Article